Literature DB >> 21142386

Andalusian Registry for familial adenomatous polyposis. Analysis of patients included.

M Garzón-Benavides1, A Pizarro-Moreno, R García-Lozano, M I Herrero-Garrido, A J Hervás-Molina, J L Márquez-Galán, C Cordero-Fernández.   

Abstract

OBJECTIVE: To evaluate the phenotype and genotype characteristic of patients included in the Andalusian Registry for familial adenomatous polyposis, the genotype/phenotype correlation and the impact of Registry in the frequency of colorectal cancer of registered.
MATERIAL AND METHODS: A descriptive study of 77 patients with FAP belonging to 33 families, included in a centralized database visited by the physicians of the hospitals taking part in the present study, on prior signing of confidentiality letters. All genetic studies were carried out in the Immunology Service of our institution.
RESULTS: We have included in our study 77 patients of 33 families; 31 probands with a mean age of 32 years (13-51) and 46 relatives at risk with a mean age of 21.8 years (6-55). Genetic study informed in 68/77 with positive result in 92.6%. Ten probands showed colorectal cancer (CRC) at the time of diagnosis (32.2%). Only two affected relatives showed CRC at diagnosis (4.3%), a statistically significant difference (p < 0.05). Gastrointestinal involvement was observed in 30/61 (49%), desmoid tumors in 7/77 (9.1%) and congenital hypertrophy of the retinal pigment epithelium in 23/55 (65.7%). 86.7% of patients with this alteration showed mutations between codons 454 and 1019, with a statistically significant correlation ((p < 0.05).
CONCLUSIONS: The registry has facilitated the genetic diagnosis for all affected families disregard their province of origin. It has also improved the screening of affected relatives and has made it possible to take preventive measures immediately, therefore diminishing the incidence of CRC at diagnosis in registered affected relatives. The correlation between congenital hypertrophy of the retinal pigment epithelium with some mutations is the only phenotypic-genotypic correlation with statistical significance.

Entities:  

Mesh:

Year:  2010        PMID: 21142386     DOI: 10.4321/s1130-01082010001100006

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  3 in total

1.  Long-term outcome of sporadic and FAP-associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patients.

Authors:  Daniel Robert Quast; Ralph Schneider; Emanuel Burdzik; Steffen Hoppe; Gabriela Möslein
Journal:  Fam Cancer       Date:  2016-01       Impact factor: 2.375

2.  Clinical characterization and mutation spectrum in Hispanic families with adenomatous polyposis syndromes.

Authors:  Marcia Cruz-Correa; Yaritza Diaz-Algorri; Vanessa Mendez; Pedro Juan Vazquez; Maria Eugenia Lozada; Katerina Freyre; Liselle Lathroum; Maria Gonzalez-Pons; Jessica Hernandez-Marrero; Francis Giardiello; Segundo Rodriguez-Quilichini
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

3.  High-resolution melting (HRM) re-analysis of a polyposis patients cohort reveals previously undetected heterozygous and mosaic APC gene mutations.

Authors:  Astrid A Out; Ivonne J H M van Minderhout; Nienke van der Stoep; Lysette S R van Bommel; Irma Kluijt; Cora Aalfs; Marsha Voorendt; Rolf H A M Vossen; Maartje Nielsen; Hans F A Vasen; Hans Morreau; Peter Devilee; Carli M J Tops; Frederik J Hes
Journal:  Fam Cancer       Date:  2015-06       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.